The Pharmaceuticals in Dosage market in Sweden exhibited fluctuating trends from 2012 to 2022, with values ranging from $9.0433 billion to $11.843 billion. Initially, the market saw significant growth in 2013 with a year-on-year increase of 10.89%, but faced a considerable dip by 2015 with an 18.02% decrease. The subsequent years showed mixed trends of recovery and decline, with notable growth spurts in 2016 (11.39%) and 2020 (12.83%). However, 2022 saw a noticeable downturn of 9.12%.
For 2023, the market is positioned value-wise at approximately $10.5 billion. The Compound Annual Growth Rate (CAGR) of the last five years stands at 1.91%, indicating modest average annual growth.
Future trends to watch for:
- Increased demand for innovative drug delivery systems.
- Expansion in biotech-driven pharmaceuticals.
- Potential impacts of regulatory changes and healthcare policies.
How does Sweden rank in Pharmaceuticals in Dosage Market Size Value?
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 12 | 12 Israel | 9,602,000,000 | 2023 | +1.67% | +1.92% | View data |
| 13 | 13 Austria | 8,922,500,000 | 2023 | +0.023% | -0.88% | View data |
| 14 | 14 Sweden | 8,549,000,000 | 2023 | -2.21% | -1.52% | |
| 15 | 15 Mexico | 8,128,300,000 | 2023 | -3.57% | -1.74% | View data |
| 16 | 16 Denmark | 7,672,000,000 | 2023 | -0.099% | -1.22% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
